NYSE:RMD - ResMed Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$98.81 +0.91 (+0.93 %)
(As of 03/21/2019 08:11 AM ET)
Previous Close$97.90
Today's Range$98.45 - $100.80
52-Week Range$90.64 - $118.50
Volume1.47 million shs
Average Volume1.07 million shs
Market Capitalization$14.16 billion
P/E Ratio27.99
Dividend Yield1.51%
Beta0.58
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Receive RMD News and Ratings via Email

Sign-up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP76115210
Phone858-836-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.34 billion
Cash Flow$4.4389 per share
Book Value$14.43 per share

Profitability

Net Income$315.58 million

Miscellaneous

Employees5,940
Market Cap$14.16 billion
Next Earnings Date4/25/2019 (Estimated)
OptionableOptionable

ResMed (NYSE:RMD) Frequently Asked Questions

What is ResMed's stock symbol?

ResMed trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMD."

How often does ResMed pay dividends? What is the dividend yield for ResMed?

ResMed announced a quarterly dividend on Friday, January 25th. Stockholders of record on Thursday, February 7th will be paid a dividend of $0.37 per share on Thursday, March 14th. This represents a $1.48 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Wednesday, February 6th. View ResMed's Dividend History.

How were ResMed's earnings last quarter?

ResMed Inc. (NYSE:RMD) issued its quarterly earnings data on Thursday, January, 24th. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.95 by $0.05. The medical equipment provider earned $651.10 million during the quarter, compared to analyst estimates of $676.77 million. ResMed had a return on equity of 26.53% and a net margin of 18.34%. ResMed's quarterly revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.00 EPS. View ResMed's Earnings History.

When is ResMed's next earnings date?

ResMed is scheduled to release their next quarterly earnings announcement on Thursday, April 25th 2019. View Earnings Estimates for ResMed.

What price target have analysts set for RMD?

8 Wall Street analysts have issued 12-month price objectives for ResMed's shares. Their forecasts range from $99.60 to $120.00. On average, they expect ResMed's share price to reach $109.80 in the next year. This suggests a possible upside of 11.1% from the stock's current price. View Analyst Price Targets for ResMed.

What is the consensus analysts' recommendation for ResMed?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ResMed in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ResMed.

Has ResMed been receiving favorable news coverage?

Media coverage about RMD stock has been trending neutral recently, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. ResMed earned a news impact score of 0.1 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the company's share price in the next few days.

Who are some of ResMed's key competitors?

What other stocks do shareholders of ResMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ResMed investors own include Visa (V), Netflix (NFLX), Walt Disney (DIS), UnitedHealth Group (UNH), NVIDIA (NVDA), salesforce.com (CRM), Adobe (ADBE), Abbott Laboratories (ABT), Intel (INTC) and Home Depot (HD).

Who are ResMed's key executives?

ResMed's management team includes the folowing people:
  • Mr. Michael J. Farrell BE, SM, MBA, CEO & Director (Age 47)
  • Mr. Robert A. Douglas, Pres & COO (Age 59)
  • Mr. Brett A. Sandercock, Chief Financial Officer (Age 52)
  • Mr. David B. Pendarvis, Chief Admin. Officer, Global Gen. Counsel & Sec. (Age 60)
  • Mr. James Hollingshead, Pres of Sleep Bus. (Age 56)

Who are ResMed's major shareholders?

ResMed's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.21%), FMR LLC (5.33%), Oregon Public Employees Retirement Fund (3.70%), Baillie Gifford & Co. (3.38%), WCM Investment Management LLC (3.02%) and Geode Capital Management LLC (1.41%). Company insiders that own ResMed stock include Brett Sandercock, David Pendarvis, Gary W Pace, James Hollingshead, John P Wareham, Jr Gregor K Emmert, Michael J Farrell, Peter C Farrell, Rajwant Sodhi, Richard Mchale, Richard Sulpizio, Robert Andrew Douglas and Ronald R Taylor. View Institutional Ownership Trends for ResMed.

Which institutional investors are selling ResMed stock?

RMD stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, D. E. Shaw & Co. Inc., FMR LLC, Gotham Asset Management LLC, Canada Pension Plan Investment Board, Congress Asset Management Co. MA, Macquarie Group Ltd. and Copeland Capital Management LLC. Company insiders that have sold ResMed company stock in the last year include Brett Sandercock, David Pendarvis, Gary W Pace, James Hollingshead, Michael J Farrell, Rajwant Sodhi, Richard Mchale, Richard Sulpizio and Robert Andrew Douglas. View Insider Buying and Selling for ResMed.

Which institutional investors are buying ResMed stock?

RMD stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, WCM Investment Management LLC, Norges Bank, BlackRock Inc., Ardevora Asset Management LLP, Retirement Systems of Alabama, Geode Capital Management LLC and First Trust Advisors LP. View Insider Buying and Selling for ResMed.

How do I buy shares of ResMed?

Shares of RMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ResMed's stock price today?

One share of RMD stock can currently be purchased for approximately $98.81.

How big of a company is ResMed?

ResMed has a market capitalization of $14.16 billion and generates $2.34 billion in revenue each year. The medical equipment provider earns $315.58 million in net income (profit) each year or $3.53 on an earnings per share basis. ResMed employs 5,940 workers across the globe.

What is ResMed's official website?

The official website for ResMed is http://www.resmed.com.

How can I contact ResMed?

ResMed's mailing address is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-836-5000 or via email at [email protected]


MarketBeat Community Rating for ResMed (NYSE RMD)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  275 (Vote Outperform)
Underperform Votes:  548 (Vote Underperform)
Total Votes:  823
MarketBeat's community ratings are surveys of what our community members think about ResMed and other stocks. Vote "Outperform" if you believe RMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/21/2019 by MarketBeat.com Staff

Featured Article: Day Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel